Form 4: Omada Health CFO Trades Shares Under 10b5-1 Plan

Omada Health's Chief Financial Officer, Steven L. Cook, executed a series of transactions involving the acquisition and disposition of company stock under a pre-established 10b5-1 trading plan.

Summary

• Steven L. Cook, Chief Financial Officer of Omada Health, Inc., reported transactions on June 30, 2026.
• Cook acquired 300 shares of common stock at a price of $8.28 per share.
• Simultaneously, Cook disposed of 300 shares of common stock at a price of $22.00 per share.
• These transactions were conducted under a Rule 10b5-1 trading plan adopted on March 14, 2026.
• Following these transactions, Cook beneficially owns 115,409 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine insider trading activity executed under a pre-defined plan, with no immediate indication of positive or negative company performance.

Positives

• The transactions were executed under a Rule 10b5-1 plan, indicating pre-planned and potentially less market-sensitive trading activity.
• The acquisition of shares at a lower price ($8.28) and disposition at a higher price ($22.00) suggests a profitable trade within the plan.
• The CFO continues to hold a significant number of shares (115,409) directly, indicating continued investment in the company.

Negatives

• The disposition of 300 shares at a significantly higher price than the acquisition price could be interpreted as the CFO taking some profit, though the volume is small relative to total holdings.

Risks

• The primary risk associated with 10b5-1 plans is the potential for misinterpretation of trading activity by the market, although the plan is designed to mitigate insider trading concerns.
• The filing does not detail any specific risks related to the company's operations or financial health.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding the company's future performance. The only forward-looking element pertains to the expiration date of a stock option.

Management Comments

• The transactions were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026.
• 100% of the shares subject to the option are fully vested and exercisable.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for executives and directors, providing transparency into their stock transactions. The use of a 10b5-1 plan by Omada Health's CFO is a common practice to manage personal stock sales and purchases in a manner that avoids potential insider trading allegations, especially relevant in the dynamic digital health sector.

Stakeholder Impact

• Shareholders: The filing provides transparency into insider trading activity, which is a standard part of corporate governance. The small volume of shares traded by the CFO is unlikely to have a significant impact on the stock price.
• Employees: The filing does not directly impact employees, though it reflects the financial activities of a key executive.
• Creditors and Suppliers: No direct impact is indicated by this filing.

Next Steps

• Continued adherence to the 10b5-1 trading plan for future transactions, if applicable.
• Monitoring of future Form 4 filings for any further changes in beneficial ownership by Steven L. Cook or other insiders.

Key Dates

Keywords

Omada Health, OMDA, Form 4, Insider Trading, 10b5-1 Plan, Steven L. Cook, Stock Transaction, Beneficial Ownership, Securities Exchange Act